As part of Effervescence 2025, Conscience is co-organizing a panel event with CQDM exploring how open science can transform drug discovery. Effervescence offers researchers, entrepreneurs, students and stakeholders in the life sciences sector a unique opportunity to showcase their knowledge, meet new people, build business relationships, participate in inspiring conferences and discover innovations in the industry, all in an experiential and stimulating environment for participants.
Our esteemed speakers – including representatives from pharmaceutical companies, AI-focused biotech firms, patient-focused non-profit drug developers, and academic researchers – will share their visions for a future where open access to data, tools, and seamless collaboration accelerates drug discovery. We invite the audience to actively participate in shaping this collective vision through real-time feedback. Together, we’ll imagine a world where open science is the norm, driving innovation and collaboration to discover the medicines patients need.
Objectives
- Promoting a New Vision of Open Drug Discovery: To highlight the importance of open and frictionless access to data, tools, and resources, enabling collaboration across sectors.
- Accelerating Innovation: To explore how open science can accelerate drug development through increased access to tools and collaboration both now and in the future.
- Education: To highlight the transformative potential and benefits of open science, fostering a broader understanding and enthusiasm for its role in revolutionizing research and drug development.
